U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H15NO.ClH
Molecular Weight 201.693
Optical Activity ( + )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Pseudoephedrine hydrochloride

SMILES

Cl.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1

InChI

InChIKey=BALXUFOVQVENIU-KXNXZCPBSA-N
InChI=1S/C10H15NO.ClH/c1-8(11-2)10(12)9-6-4-3-5-7-9;/h3-8,10-12H,1-2H3;1H/t8-,10+;/m0./s1

HIDE SMILES / InChI

Molecular Formula C10H15NO
Molecular Weight 165.2322
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12373557 | http://www.mayoclinic.org/drugs-supplements/ephedra--ma-huang/background/hrb-20059270 | https://www.sudafed.com/adult-products/congestion/sudafed-24-hour#uses-and-directions | https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0011888 | https://www.ncbi.nlm.nih.gov/pubmed/11772135 | https://www.ncbi.nlm.nih.gov/pubmed/10449190 | https://www.ncbi.nlm.nih.gov/pubmed/12954796

Pseudoephedrine is a sympathomimetic drug. Pseudoephedrine acts as an adrenomimetic and inhibitor of monoamine transporters. Ephedra sinica, a species of ephedra (ma huang), contains ephedrine and pseudoephedrine. Ephedra has been found to stimulate the nervous system, increase airflow into the lungs and constrict blood vessels. In combination with caffeine, ephedra appears to cause weight loss. Pseudoephedrine is a decongestant that shrinks blood vessels in the nasal passages. Pseudoephedrine is used to relieve nasal or sinus congestion caused by the common cold, sinusitis, and hay fever and other respiratory allergies.

Originator

Sources: A. Ladenburg, C. Oelschlägel, Ber. 22, 1823 (1889).
Curator's Comment: (+)-threo-isomer of ephedrine, q.v. Isoln from E. vulgaris: A. Ladenburg, C. Oelschlägel, Ber. 22, 1823 (1889). Synthesis: E. Späth, R. Göhring, Monatsh. Chem. 41, 319 (1920). reference retrieved from http://www.drugfuture.com/chemdata/pseudoephedrine.html

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
SUDAFED 24 HOUR

Approved Use

temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies; reduces swelling of nasal passages; relieves sinus pressure

Launch Date

1992
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
292 ng/mL
120 mg single, oral
dose: 120 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
PSEUDOEPHEDRINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
4346 ng × h/mL
120 mg single, oral
dose: 120 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
PSEUDOEPHEDRINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
6.3 h
120 mg single, oral
dose: 120 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
PSEUDOEPHEDRINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
Doses

Doses

DosePopulationAdverse events​
1500 mg single, oral
Overdose
Dose: 1500 mg
Route: oral
Route: single
Dose: 1500 mg
Sources:
unknown, 16 years
n = 1
Health Status: unknown
Age Group: 16 years
Sex: F
Population Size: 1
Sources:
Other AEs: Rhabdomyolysis, Creatine kinase increased...
Other AEs:
Rhabdomyolysis (1 patient)
Creatine kinase increased (1 patient)
Blood myoglobin increased (1 patient)
Sources:
150 mg 2 times / day multiple, oral
Highest studied dose
Dose: 150 mg, 2 times / day
Route: oral
Route: multiple
Dose: 150 mg, 2 times / day
Sources:
healthy, 24 years
n = 17
Health Status: healthy
Age Group: 24 years
Sex: M
Population Size: 17
Sources:
Other AEs: Tension, Dry mouth...
Other AEs:
Tension (10 patients)
Dry mouth (6 patients)
Tachycardia (9 patients)
Palpitations (10 patients)
Anxiety (13 patients)
Insomnia (12 patients)
Anorexia (7 patients)
Restlessness (10 patients)
Sources:
90 mg 1 times / day multiple, oral
Overdose
Dose: 90 mg, 1 times / day
Route: oral
Route: multiple
Dose: 90 mg, 1 times / day
Sources:
unhealthy, 3 years
n = 1
Health Status: unhealthy
Age Group: 3 years
Sex: M
Population Size: 1
Sources:
Disc. AE: Urinary retention...
AEs leading to
discontinuation/dose reduction:
Urinary retention (acute, 1 patient)
Sources:
30 mg 2 times / day multiple, oral
Dose: 30 mg, 2 times / day
Route: oral
Route: multiple
Dose: 30 mg, 2 times / day
Co-administed with::
acetominophen(500 mg twice daily, oral)
Sources:
unhealthy, 37 years
n = 1
Health Status: unhealthy
Condition: sinusitis
Age Group: 37 years
Sex: F
Population Size: 1
Sources:
Disc. AE: Ischemic colitis, Abdominal pain...
AEs leading to
discontinuation/dose reduction:
Ischemic colitis (1 patient)
Abdominal pain (acute, 1 patient)
Sources:
720 mg 1 times / day multiple, oral
Highest studied dose
Dose: 720 mg, 1 times / day
Route: oral
Route: multiple
Dose: 720 mg, 1 times / day
Sources:
unhealthy, 38.8 years
n = 38
Health Status: unhealthy
Age Group: 38.8 years
Sex: M+F
Population Size: 38
Sources:
30 mg 3 times / day multiple, oral
Dose: 30 mg, 3 times / day
Route: oral
Route: multiple
Dose: 30 mg, 3 times / day
Sources:
unhealthy, 44 years
n = 1
Health Status: unhealthy
Condition: upper airway infection
Age Group: 44 years
Sex: F
Population Size: 1
Sources:
Disc. AE: Ischemic colitis, Abdominal pain...
AEs leading to
discontinuation/dose reduction:
Ischemic colitis (1 patient)
Abdominal pain (acute, 1 patient)
Sources:
120 mg 1 times / day multiple, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: multiple
Dose: 120 mg, 1 times / day
Sources:
unhealthy, 46 years
n = 1
Health Status: unhealthy
Condition: chronic sinusitis | allergic rhinitis
Age Group: 46 years
Sex: F
Population Size: 1
Sources:
Disc. AE: Ischemic colitis, Abdominal pain...
AEs leading to
discontinuation/dose reduction:
Ischemic colitis (1 patient)
Abdominal pain (acute, 1 patient)
Sources:
30 mg 2 times / day multiple, oral
Dose: 30 mg, 2 times / day
Route: oral
Route: multiple
Dose: 30 mg, 2 times / day
Co-administed with::
acetominophen(500 mg twice daily, oral)
chlorpheniramine maleate(2 mg; twice daily, oral)
Sources:
unhealthy, 50 years
n = 1
Health Status: unhealthy
Condition: rhinitis
Age Group: 50 years
Sex: F
Population Size: 1
Sources:
Disc. AE: Ischemic colitis, Abdominal pain...
AEs leading to
discontinuation/dose reduction:
Ischemic colitis (1 patient)
Abdominal pain (acute, 1 patient)
Sources:
720 mg single, oral
Overdose
Dose: 720 mg
Route: oral
Route: single
Dose: 720 mg
Sources:
unhealthy, 87 years
n = 1
Health Status: unhealthy
Age Group: 87 years
Sex: M
Population Size: 1
Sources:
Other AEs: Hypertension...
Other AEs:
Hypertension (1 patient)
Sources:
AEs

AEs

AESignificanceDosePopulation
Blood myoglobin increased 1 patient
1500 mg single, oral
Overdose
Dose: 1500 mg
Route: oral
Route: single
Dose: 1500 mg
Sources:
unknown, 16 years
n = 1
Health Status: unknown
Age Group: 16 years
Sex: F
Population Size: 1
Sources:
Creatine kinase increased 1 patient
1500 mg single, oral
Overdose
Dose: 1500 mg
Route: oral
Route: single
Dose: 1500 mg
Sources:
unknown, 16 years
n = 1
Health Status: unknown
Age Group: 16 years
Sex: F
Population Size: 1
Sources:
Rhabdomyolysis 1 patient
1500 mg single, oral
Overdose
Dose: 1500 mg
Route: oral
Route: single
Dose: 1500 mg
Sources:
unknown, 16 years
n = 1
Health Status: unknown
Age Group: 16 years
Sex: F
Population Size: 1
Sources:
Palpitations 10 patients
150 mg 2 times / day multiple, oral
Highest studied dose
Dose: 150 mg, 2 times / day
Route: oral
Route: multiple
Dose: 150 mg, 2 times / day
Sources:
healthy, 24 years
n = 17
Health Status: healthy
Age Group: 24 years
Sex: M
Population Size: 17
Sources:
Restlessness 10 patients
150 mg 2 times / day multiple, oral
Highest studied dose
Dose: 150 mg, 2 times / day
Route: oral
Route: multiple
Dose: 150 mg, 2 times / day
Sources:
healthy, 24 years
n = 17
Health Status: healthy
Age Group: 24 years
Sex: M
Population Size: 17
Sources:
Tension 10 patients
150 mg 2 times / day multiple, oral
Highest studied dose
Dose: 150 mg, 2 times / day
Route: oral
Route: multiple
Dose: 150 mg, 2 times / day
Sources:
healthy, 24 years
n = 17
Health Status: healthy
Age Group: 24 years
Sex: M
Population Size: 17
Sources:
Insomnia 12 patients
150 mg 2 times / day multiple, oral
Highest studied dose
Dose: 150 mg, 2 times / day
Route: oral
Route: multiple
Dose: 150 mg, 2 times / day
Sources:
healthy, 24 years
n = 17
Health Status: healthy
Age Group: 24 years
Sex: M
Population Size: 17
Sources:
Anxiety 13 patients
150 mg 2 times / day multiple, oral
Highest studied dose
Dose: 150 mg, 2 times / day
Route: oral
Route: multiple
Dose: 150 mg, 2 times / day
Sources:
healthy, 24 years
n = 17
Health Status: healthy
Age Group: 24 years
Sex: M
Population Size: 17
Sources:
Dry mouth 6 patients
150 mg 2 times / day multiple, oral
Highest studied dose
Dose: 150 mg, 2 times / day
Route: oral
Route: multiple
Dose: 150 mg, 2 times / day
Sources:
healthy, 24 years
n = 17
Health Status: healthy
Age Group: 24 years
Sex: M
Population Size: 17
Sources:
Anorexia 7 patients
150 mg 2 times / day multiple, oral
Highest studied dose
Dose: 150 mg, 2 times / day
Route: oral
Route: multiple
Dose: 150 mg, 2 times / day
Sources:
healthy, 24 years
n = 17
Health Status: healthy
Age Group: 24 years
Sex: M
Population Size: 17
Sources:
Tachycardia 9 patients
150 mg 2 times / day multiple, oral
Highest studied dose
Dose: 150 mg, 2 times / day
Route: oral
Route: multiple
Dose: 150 mg, 2 times / day
Sources:
healthy, 24 years
n = 17
Health Status: healthy
Age Group: 24 years
Sex: M
Population Size: 17
Sources:
Urinary retention acute, 1 patient
Disc. AE
90 mg 1 times / day multiple, oral
Overdose
Dose: 90 mg, 1 times / day
Route: oral
Route: multiple
Dose: 90 mg, 1 times / day
Sources:
unhealthy, 3 years
n = 1
Health Status: unhealthy
Age Group: 3 years
Sex: M
Population Size: 1
Sources:
Ischemic colitis 1 patient
Disc. AE
30 mg 2 times / day multiple, oral
Dose: 30 mg, 2 times / day
Route: oral
Route: multiple
Dose: 30 mg, 2 times / day
Co-administed with::
acetominophen(500 mg twice daily, oral)
Sources:
unhealthy, 37 years
n = 1
Health Status: unhealthy
Condition: sinusitis
Age Group: 37 years
Sex: F
Population Size: 1
Sources:
Abdominal pain acute, 1 patient
Disc. AE
30 mg 2 times / day multiple, oral
Dose: 30 mg, 2 times / day
Route: oral
Route: multiple
Dose: 30 mg, 2 times / day
Co-administed with::
acetominophen(500 mg twice daily, oral)
Sources:
unhealthy, 37 years
n = 1
Health Status: unhealthy
Condition: sinusitis
Age Group: 37 years
Sex: F
Population Size: 1
Sources:
Ischemic colitis 1 patient
Disc. AE
30 mg 3 times / day multiple, oral
Dose: 30 mg, 3 times / day
Route: oral
Route: multiple
Dose: 30 mg, 3 times / day
Sources:
unhealthy, 44 years
n = 1
Health Status: unhealthy
Condition: upper airway infection
Age Group: 44 years
Sex: F
Population Size: 1
Sources:
Abdominal pain acute, 1 patient
Disc. AE
30 mg 3 times / day multiple, oral
Dose: 30 mg, 3 times / day
Route: oral
Route: multiple
Dose: 30 mg, 3 times / day
Sources:
unhealthy, 44 years
n = 1
Health Status: unhealthy
Condition: upper airway infection
Age Group: 44 years
Sex: F
Population Size: 1
Sources:
Ischemic colitis 1 patient
Disc. AE
120 mg 1 times / day multiple, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: multiple
Dose: 120 mg, 1 times / day
Sources:
unhealthy, 46 years
n = 1
Health Status: unhealthy
Condition: chronic sinusitis | allergic rhinitis
Age Group: 46 years
Sex: F
Population Size: 1
Sources:
Abdominal pain acute, 1 patient
Disc. AE
120 mg 1 times / day multiple, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: multiple
Dose: 120 mg, 1 times / day
Sources:
unhealthy, 46 years
n = 1
Health Status: unhealthy
Condition: chronic sinusitis | allergic rhinitis
Age Group: 46 years
Sex: F
Population Size: 1
Sources:
Ischemic colitis 1 patient
Disc. AE
30 mg 2 times / day multiple, oral
Dose: 30 mg, 2 times / day
Route: oral
Route: multiple
Dose: 30 mg, 2 times / day
Co-administed with::
acetominophen(500 mg twice daily, oral)
chlorpheniramine maleate(2 mg; twice daily, oral)
Sources:
unhealthy, 50 years
n = 1
Health Status: unhealthy
Condition: rhinitis
Age Group: 50 years
Sex: F
Population Size: 1
Sources:
Abdominal pain acute, 1 patient
Disc. AE
30 mg 2 times / day multiple, oral
Dose: 30 mg, 2 times / day
Route: oral
Route: multiple
Dose: 30 mg, 2 times / day
Co-administed with::
acetominophen(500 mg twice daily, oral)
chlorpheniramine maleate(2 mg; twice daily, oral)
Sources:
unhealthy, 50 years
n = 1
Health Status: unhealthy
Condition: rhinitis
Age Group: 50 years
Sex: F
Population Size: 1
Sources:
Hypertension 1 patient
720 mg single, oral
Overdose
Dose: 720 mg
Route: oral
Route: single
Dose: 720 mg
Sources:
unhealthy, 87 years
n = 1
Health Status: unhealthy
Age Group: 87 years
Sex: M
Population Size: 1
Sources:
PubMed

PubMed

TitleDatePubMed
A Double-blind crossover trial of pseudoephedrine and triprolidine, alone and in combination, for the treatment of allergenic rhinitis.
1975 Jan
Cetirizine/pseudoephedrine.
2001
Recurrent ischaemic colitis associated with pseudoephedrine use.
2001 Apr
Ischaemic colitis on pseudoephedrine.
2001 Aug
Stereocontrolled Mannich reaction with enolizable imines using (S,S)-(+)-pseudoephedrine as chiral auxiliary. Asymmetric synthesis of alpha,beta-disubstituted beta-aminoesters and beta-lactams.
2001 Dec 28
New observations on the secondary chemistry of world Ephedra (Ephedraceae).
2001 Jul
Comparative oral and topical decongestant effects of phenylpropanolamine and d-pseudoephedrine.
2001 Mar-Apr
Acute myocardial ischemia associated with ingestion of bupropion and pseudoephedrine in a 21-year-old man.
2001 May
Epinephrine analogues.
2001 Nov
[Separation and determination of pseudoephedrine in bufferin cold tablet by capillary electrophoresis with hydropropyl-beta-cyclodextrin as chiral selective reagent].
2001 Nov
Chloroephedrine: contaminant of methamphetamine synthesis with cardiovascular activity.
2001 Nov 1
Biotransformation of benzaldehyde into (R)-phenylacetylcarbinol by filamentous fungi or their extracts.
2001 Oct
Cathinone (Khat) and methcathinone (CAT) in urine specimens: a gas chromatographic-mass spectrometric detection procedure.
2001 Oct
Relationship between expansion of the CAG repeat in exon 1 of the androgen receptor gene and idiopathic male infertility.
2001 Oct
Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations.
2001 Sep
Separation and determination of ephedrine alkaloids and tetramethylpyrazine in Ephedra sinica Stapf by gas chromatography-mass spectrometry.
2001 Sep
Toxicity of over-the-counter cough and cold medications.
2001 Sep
Kinetic spectrophotometric methods for the quantitation of triprolidine in bulk and in drug formulations.
2001 Sep
Rapid chiral on-chip separation with simplified amperometric detection.
2001 Sep 14
Analysis of enantiomers giving partially overlapped peaks by using different treatments of the chromatographic ultraviolet signals: quantification of pseudoephedrine enantiomers.
2001 Sep 28
Myocardial infarction temporally related to ephedra--a possible role for the coronary microcirculation.
2002
Liquid chromatography/tandem mass spectrometric bioanalysis using normal-phase columns with aqueous/organic mobile phases - a novel approach of eliminating evaporation and reconstitution steps in 96-well SPE.
2002
Generalized dermatitis due to pseudoephedrine.
2002 Aug
Evaluation of a pseudoephedrine linker for asymmetric alkylations on solid phase.
2002 Dec 26
Maternal medication use and risks of gastroschisis and small intestinal atresia.
2002 Jan 1
Cerebral vasoconstriction and stroke after use of serotonergic drugs.
2002 Jan 8
Modifying the bitterness of selected oral pharmaceuticals with cation and anion series of salts.
2002 Jul
Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
2002 Jul
Erythrodermia to pseudoephedrine in a patient with contact allergy to phenylephrine.
2002 Jul-Aug
Rapid simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, and 3,4-methylenedioxyethylamphetamine in urine by solid-phase extraction and GC-MS: a method optimized for high-volume laboratories.
2002 Jul-Aug
Oral medications.
2002 Mar
Pseudoephedrine as a chiral auxiliary for asymmetric Michael reactions: synthesis of 3-aryl-delta-lactones.
2002 May 30
Enantiomeric separation of methamphetamine and related analogs by capillary zone electrophoresis: intelligence study in routine methamphetamine seizures.
2002 Nov
Enhanced enantio- and diastereoselectivity via confinement and cation binding: yang photocyclization of 2-benzoyladamantane derivatives within zeolites.
2002 Nov 29
Quantitative and structural determination of pseudoephedrine sulfate and its related compounds in pharmaceutical preparations using high-performance liquid chromatography.
2002 Nov 7
[Cutaneous complications following liver transplantation: epidemiologic and clinical study in 86 patients].
2002 Oct
Severe adverse drug reactions due to pseudoephedrine from over-the-counter medications.
2002 Sep
Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion.
2002 Sep-Oct
Sensitive determination of ephedrine and pseudoephedrine by capillary electrophoresis with laser-induced fluorescence detection.
2003 Apr
Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study.
2003 Jan
Press-coating of immediate release powders onto coated controlled release tablets with adhesives.
2003 May 20
Patents

Sample Use Guides

SUDAFED® 24 HOUR TABLET, EXTENDED RELEASE; ORAL (PSEUDOEPHEDRINE HYDROCHLORIDE) 240MG adults and children 12 years and older: a tablet with water every 24 hours children under 12 years: do not use this product in children under 12 years of age
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: Pseudoephedrine inhibits interleukin-2 (IL-2) and tumor necrosis factor (TNF) alpha-gene transcription in stimulated Jurkat cells, a human T-cell leukemia cell line.
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 19:06:44 GMT 2023
Edited
by admin
on Sat Dec 16 19:06:44 GMT 2023
Record UNII
6V9V2RYJ8N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Pseudoephedrine hydrochloride
EP   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN  
Official Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF ALLEGRA-D
Common Name English
ACTAHIST COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
CODIMAL-L.A. 12 COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
BROMANATE DM COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
ALLERFED COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
RHINALAIR
Brand Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF HISTAFED
Common Name English
SINE-AID IB COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF ALEVE-D
Common Name English
TRIACIN-C COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
TRIPHED COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
MYFED COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE [EP MONOGRAPH]
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF CODIMAL-L.A. 12
Common Name English
HISTAFED COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF CHILDREN'S ADVIL COLD
Common Name English
ALLEGRA-D COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE [ORANGE BOOK]
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF ACTIFED
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF SINE-AID IB
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF BROMANATE DM
Common Name English
TRILITRON COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF ADVIL ALLERGY SINUS
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE [MART.]
Common Name English
CORPHED COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF TRIPHED
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF ZYRTEC-D
Common Name English
GALSUD
Brand Name English
DIMETANE-DX COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF TRILITRON
Common Name English
SEMPREX-D COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
CHILDREN'S ADVIL COLD COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
SUDAFED
Brand Name English
PSEUDOEPHEDRINE HYDROCHLORIDE [USP-RS]
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE [MI]
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE [USAN]
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF MYFED
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF BROMFED-DM
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF DIMETANE-DX
Common Name English
HYCOFENIX COMPONENT OF PSEUDOEPHEDRINE HYDROCHLORIDE
Brand Name English
OTRINOL
Brand Name English
ZYRTEC-D COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
NSC-33634
Code English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF TRIACIN-C
Common Name English
BROMFED-DM COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
Pseudoephedrine hydrochloride [WHO-DD]
Common Name English
CHILDREN'S MOTRIN COLD COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF ALLERFED
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF MUCINEX D
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE [VANDF]
Common Name English
EFIDAC 24
Brand Name English
PSEUDOEPHEDRINE HYDROCHLORIDE [USP MONOGRAPH]
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF CHILDREN'S MOTRIN COLD
Common Name English
PSEUDOEPHEDRINE HCL
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF ISOCLOR
Common Name English
MUCINEX D COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF SEMPREX-D
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF ACTAHIST
Common Name English
ADVIL ALLERGY SINUS COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
ALEVE-D COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
ACTIFED COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF HYCOFENIX
Brand Name English
GALPSEUD
Brand Name English
ISOCLOR COMPONENT PSEUDOEPHEDRINE HYDROCHLORIDE
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE COMPONENT OF CORPHED
Common Name English
NSC-106567
Code English
Classification Tree Code System Code
NCI_THESAURUS C29709
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
CFR 21 CFR 341.20
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
DEA NO. 8112
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
Code System Code Type Description
NSC
106567
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
DAILYMED
6V9V2RYJ8N
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
SMS_ID
100000092030
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
EVMPD
SUB04119MIG
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
RS_ITEM_NUM
1581005
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
NCI_THESAURUS
C29390
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
ChEMBL
CHEMBL1590
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
EPA CompTox
DTXSID10889343
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
CAS
345-78-8
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
RXCUI
91168
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY RxNorm
NSC
33634
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
ECHA (EC/EINECS)
206-462-1
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
DRUG BANK
DBSALT000149
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
PUBCHEM
9581
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
FDA UNII
6V9V2RYJ8N
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY
MERCK INDEX
m9294
Created by admin on Sat Dec 16 19:06:44 GMT 2023 , Edited by admin on Sat Dec 16 19:06:44 GMT 2023
PRIMARY Merck Index
Related Record Type Details
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
Term
PARENT -> SALT/SOLVATE
BASIS OF STRENGTH->SUBSTANCE
ASSAY (TITRATION)
EP
PARENT -> SALT/SOLVATE
Related Record Type Details
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY